Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is GenFleet Therapeutics (Shanghai) Days Inventory?
GenFleet Therapeutics (Shanghai)HAM:Y3L -2.80%19 Days Inventory is 56.12 as of Dec. 2025, which is 37% below its 10-year median of 89.02. GuruFocus rates HAM:Y3L with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, GenFleet Therapeutics (Shanghai) ranks better than 82.6% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
GenFleet Therapeutics (Shanghai)'s Inventory Turnover for the
six
months ended in Dec. 2025 was 3.25.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GenFleet Therapeutics (Shanghai)'s Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.22.
GenFleet Therapeutics (Shanghai) (HAM:Y3L) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
GenFleet Therapeutics (Shanghai)'s Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GenFleet Therapeutics (Shanghai)'s Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
GenFleet Therapeutics (Shanghai) Days Inventory Related Terms
GenFleet Therapeutics (Shanghai) Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GenFleet Therapeutics (Shanghai) Days Inventory Chart
GenFleet Therapeutics (Shanghai) Annual Data
Trend
Dec23
Dec24
Dec25
Days Inventory
1,107.59
69.03
91.56
GenFleet Therapeutics (Shanghai) Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
Days Inventory
0.00
0.00
50.75
37.74
56.12
HAM:Y3L vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, GenFleet Therapeutics (Shanghai)'s Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GenFleet Therapeutics (Shanghai) Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GenFleet Therapeutics (Shanghai)'s Days Inventory distribution charts can be found below:
* The bar in red indicates where GenFleet Therapeutics (Shanghai)'s Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GenFleet Therapeutics (Shanghai) (HAM:Y3L) has a Days Inventory of 56.12 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GenFleet Therapeutics (Shanghai) and its competitors. This is 37% below median its historical median of 89.02. Over the past decade, GenFleet Therapeutics (Shanghai)'s Days Inventory has ranged from 61.97 to 1,098.42. According to the industry distribution chart, GenFleet Therapeutics (Shanghai) ranks #111 out of 638 companies in the Biotechnology industry, placing it in the top 17.4%.
Is GenFleet Therapeutics (Shanghai)'s Days Inventory too high?
GenFleet Therapeutics (Shanghai)'s current Days Inventory of 56.12 is 37% below median its 10-year median of 89.02. Over the past 10 years, this metric has ranged from a low of 61.97 to a high of 1,098.42. The Biotechnology industry median Days Inventory is 182.25. GenFleet Therapeutics (Shanghai)'s value of 56.12 is 69.2% below this industry median. Based on the distribution chart, GenFleet Therapeutics (Shanghai) ranks #111 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GenFleet Therapeutics (Shanghai) has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does GenFleet Therapeutics (Shanghai)'s Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GenFleet Therapeutics (Shanghai) ranks #111 out of 638 companies for Days Inventory. This places GenFleet Therapeutics (Shanghai) in the top 17% of its industry — outperforming the majority of peers. The industry median Days Inventory is 182.25. GenFleet Therapeutics (Shanghai)'s value of 56.12 is 69.2% below this benchmark. Historically, GenFleet Therapeutics (Shanghai)'s own Days Inventory has ranged from 61.97 to 1,098.42 over the past decade. While the company's 10-year median is 89.02 vs. the industry median of 182.25, GenFleet Therapeutics (Shanghai) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 182.25, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GenFleet Therapeutics (Shanghai)'s current Days Inventory of 56.12 is 69.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GenFleet Therapeutics (Shanghai) and its competitors. For the Biotechnology industry, the median Days Inventory is 182.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GenFleet Therapeutics (Shanghai)'s current Days Inventory is 56.12, which is 37% below median its own 10-year median of 89.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenFleet Therapeutics (Shanghai) stock overvalued right now?
GenFleet Therapeutics (Shanghai) (HAM:Y3L) has a current Days Inventory of 56.12. The current Days Inventory is 56.12, which is 37% below median its 10-year median of 89.02 and 69.2% below the Biotechnology industry median of 182.25. GenFleet Therapeutics (Shanghai)'s overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For GenFleet Therapeutics (Shanghai) (HAM:Y3L), the current Days Inventory is 56.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GenFleet Therapeutics (Shanghai) Inc Company is a clinical-stage biotechnology company. The Company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment.
19GF Score
Get the complete analysis for HAM:Y3L
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:Y3L has been successfully added to your 
